Biogen | Despesa De Juros Sobre A Dívida



Interest Expense On Debt Alterar Data
AbbVie USD 610M 19M 2024-12
ALKERMES USD 4.65M 1.35M 2024-12
Amgen USD 747M 29M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 248M 10M 2024-12
Incyte USD 419K 355K 2024-12
Merck USD 328M 2M 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sanofi 62M 17M 2024-12
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Biogen Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.